文献速递神经外周血管MR

乙酰唑胺增强BOLD MRI主成分分析评估慢性狭窄闭塞病全脑脑血管反应性

Acetazolamide-augmented BOLD MRI to Assess Whole-Brain Cerebrovascular Reactivity in Chronic Steno-occlusive Disease Using Principal Component Analysis.
PubMed 文献 · Radiology · 2023-03-14

该回顾性研究纳入23例单侧慢性狭窄闭塞病患者共32次乙酰唑胺增强BOLD检查,采用主成分分析去噪框架将信噪比提升两倍,实现全脑动态CVR分析。结果显示病变半球和健康半球的平均CVRmax均显著高于CVRend,并观察到无反应、延迟/减弱、快速及非单调用药后时间信号特征。

要点

  • 主成分分析去噪使BOLD信噪比提升两倍,可逐TR(约2秒)提取动态CVRmax。
  • 病变半球CVRmax均值5.2%显著高于CVRend的3.8%,健康半球为5.5% vs 4.0%。
  • 用药后时间信号可见无反应、延迟/减弱、快速及非单调(窃血/反向窃血)模式。

核心结论

  • 基于主成分分析的计算框架通过两倍信噪比提升,可测量未持续的最大脑血管反应性CVRmax。

研究设计与样本

  • 共纳入23例患者(中位年龄51岁,IQR 42-61,男13例),完成32次BOLD检查。
  • 采用基于主成分分析的局部去噪流程校正空间变化的非信号贡献,生成体素级CVRend图并与分箱去噪时间课程提取的CVRmax比较。
  • 使用线性混合效应模型比较健康与病变半球的CVRmax和CVRend。

关键影像表现/征象

  • 处理后MRI数据信噪比提升两倍,可分离信号时间课程的动态特征至每个BOLD重复时间(约2秒)水平。
  • 病变半球平均CVRmax为5.2%,显著高于CVRend的3.8%(P < .01)。
  • 健康半球平均CVRmax为5.5%,显著高于CVRend的4.0%(P < .01)。
  • 在正常和异常组织中观察到多种时间信号特征,包括无反应、延迟/减弱、快速以及偶见非单调伴矛盾特征(窃血和反向窃血模式)。

临床应用与阅片要点

  • 日常阅片可关注乙酰唑胺增强BOLD MRI的动态CVRmax,而非仅终末CVRend,以捕捉未持续的反应特征。
  • 报告中可描述时间信号模式(无反应、延迟/减弱、快速、非单调窃血/反向窃血),辅助评估狭窄闭塞病的血流动力学损害。

局限性

  • 回顾性单中心研究,样本量有限(23例患者32次检查)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Exhaustion of cerebrovascular reactivity (CVR) portends increased stroke risk. Acetazolamide-augmented blood oxygenation level-dependent (BOLD) MRI has been used to estimate CVR, but low signal-to-noise conditions relegate its use to terminal CVR (CVRend) measurements that neglect dynamic features of CVR. Purpose To demonstrate comprehensive characterization of acetazolamide-augmented BOLD MRI response in chronic steno-occlusive disease using a computational framework to precondition signal time courses for dynamic whole-brain CVR analysis. Materials and Methods This study focused on retrospective analysis of consecutive patients with unilateral chronic steno-occlusive disease who underwent acetazolamide-augmented BOLD imaging for recurrent minor stroke or transient ischemic attack at an academic medical center between May 2017 and October 2020. A custom principal component analysis-based denoising pipeline was used to correct spatially varying non-signal-bearing contributions obtained by a local principal component analysis of the MRI time series. Standard voxelwise CVRend maps representing terminal responses were produced and compared with maximal CVR (CVRmax) as isolated from binned (per-repetition time) denoised BOLD time course. A linear mixed-effects model was used to compare CVRmax and CVRend in healthy and diseased hemispheres. Results A total of 23 patients (median age, 51 years; IQR, 42-61, 13 men) who underwent 32 BOLD examinations were included. Processed MRI data showed twofold improvement in signal-to-noise ratio, allowing improved isolation of dynamic characteristics in signal time course for sliding window CVRmax analysis to the level of each BOLD repetition time (approximately 2 seconds). Mean CVRmax was significantly higher than mean CVRend in diseased (5.2% vs 3.8%, P < .01) and healthy (5.5% vs 4.0%, P < .01) hemispheres. Several distinct time-signal signatures were observed, including nonresponsive; delayed/blunted; brisk; and occasionally nonmonotonic time courses with paradoxical features in normal and abnormal tissues (ie, steal and reverse-steal patterns). Conclusion A principal component analysis-based computational framework for analysis of acetazolamide-augmented BOLD imaging can be used to measure unsustained CVRmax through twofold improvements in signal-to-noise ratio. © RSNA, 2023 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Dogra, Wang, Gupta, et al. Acetazolamide-augmented BOLD MRI to Assess Whole-Brain Cerebrovascular Reactivity in Chronic Steno-occlusive Disease Using Principal Component Analysis. Radiology. 2023. PMID: 36916889. doi:10.1148/radiol.221473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。